Reem Suliman

7PUBLICATIONS
21CO-AUTHORS
Traditional Chinese medicine and treatmentsEpidemiological methodsFood properties (incl. characteristics and health benefits)Regenerative medicine (incl. stem cells)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 19, 2026
Efficacy, Safety, and Tolerability of Atogepant in Migraine Patients from the UAE.

|Apr 09, 2026
Migraine Patients Treated With Erenumab and the Risk of Hypertension: A Registry-Based Real-World Study.

Christian Lampl, Reem Suliman, Viktoria Tischler-Strasser

|Jul 30, 2025
A randomized open-label study to evaluate the effectiveness and safety of once-daily rimegepant 75 mg orally disintegrating tablet for the short-term preventive treatment of fasting-triggered headache in individuals with migraine.

Taoufik Alsaadi, Reem Suliman, Jiyue Yang

|Feb 29, 2024
Impacts of chitosan and its nanoformulations on the metabolic syndromes: a review.

M E Abd El-Hack, M Kamal, R S Alazragi

|Feb 23, 2024
Effectiveness of Switching CGRP Monoclonal Antibodies in Non-Responder Patients in the UAE: A Retrospective Study.

Reem Suliman, Vanessa Santos, Ibrahim Al Qaisi

|Feb 16, 2024
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study.

Taoufik Alsaadi, Reem Suliman, Vanessa Santos

Pageof 2

Frequent Collaborators

6 joint publications

Taoufik Alsaadi

1 joint publications

M E Abd El-Hack

1 joint publications

M Kamal

1 joint publications

R M Alreemi